Enzolytics Meets With Major Retailers at Recent ECRM Event
Oct 8, 2022
Company Wants to Roll Out IPF Immune™ to American Consumers
(PRUnderground) October 7th, 2022
Enzolytics, Inc. promoted its IPF Immune™, a dietary supplement that supports the immune system, to dozens of retail buyers at the recent ECRM’s “Vitamin, Weight Management, and Sports Nutrition Program.”
“We had a great opportunity to pitch IPF Immune™ to some of the most sought-after retailers in the country,” said Charles S. Cotropia, CEO of Enzolytics, Inc., a Texas-based biotech company “We are reviewing the responses the buyers had and plan to follow up with them.
“We will be sending them samples and any additional information they need to make a a positive decision on carrying IPF Immune™,” Mr. Cotropia said. “We are working hard to add retail outlets in the coming months.”
ECRM brings buyers and brands with new products together for private meetings. Buyers attending the ECRM event represent regional and national food, drug, and mass chains.
Mr. Cotropia said retailers should want a product like IPF Immune™ because interest in immune boosters skyrocketed during the pandemic.
“Everyone is more focused on their health now,” he added. “They want to keep themselves healthy rather than wait until they are ill.”
IPF Immune™ is a dietary supplement that supports the body’s immune system by promoting normal immune function. It is a gluten-free dietary supplement that is taken orally two consecutive days per week for eight consecutive weeks.
“IPF Immune™ is a dietary supplement for the post-pandemic era,” Mr. Cotropia said. “Retailers know what consumers want and we believe our product is what they want.”
For more information, email [email protected] or visit enzolytics.com.
Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. This press release is not a substitute for professional medical advice, diagnosis, or treatment. Please check with your doctor. The news site hosting this press release is not associated with Enzolytics, Inc. It is merely publishing a press release announcement submitted by a company, without any stated or implied endorsement of the product or service.
About Enzolytics, Inc.
Enzolytics Inc. is a Texas-based biotechnology company that focuses on therapeutics to treat numerous human health medical conditions. In addition to Enzolytics IPF Immune™, which will be on the U.S. market soon, the Company is developing other therapeutics for treating multiple infectious diseases, including monoclonal antibodies for treating COVID-19 and HIV, and anti-cancer therapeutics.
The post Enzolytics Meets With Major Retailers at Recent ECRM Event first appeared on PRUnderground.
Press Contact
Name: Robert Grant Phone: 5615440719 Email: Contact Us Website: https://inhealthmedia.com/Original Press Release.
More News
Aurum hits more golden paydirt beyond West African resource
Aurum has hit bonanza gold, including 0.65m at 41.38g/t, outside its BST1 resource at the 3.22Moz Boundiali project, ahead of a key gold resource update due this month.
Forrestania fast-tracks WA gold production for December
Forrestania is fast-tracking its Edna May gold restart for December. First ore is on the pad, mill liners are en route, and mining has mobilised.
December rare earths production debut looms for Lindian in Malawi
Lindian Resources is set for first rare earths production in December at its Kangankunde project in Malawi, with construction and power infrastructure nearly complete.
Miners and tech stocks rally, taking ASX to third week of gains
The Australian sharemarket has clocked a third straight positive week despite a brutal mid-week sell-down, as investors grapple with fast-moving market risks.
Dating apps are supposed to make money and help people find love. Are they doing neither?
“The worst thing possible for Hinge is for people to fall in love,” says Australian writer Alistair Kitchen, who has created his own app to rival it.
TVSN fires off legal letters as war with suppliers escalates
TVSN director Bernie Brookes is refusing to hand the business over to administrators as suppliers become infuriated with the home shopping network’s radio silence.
McKinsey leader steps down from charity board after controversial ‘glass cliff’ comments
Chris Bradley resigned from Opportunity International Australia just days after his controversial remarks about the challenges female CEOs face.
The three factors driving NSW unemployment to a five-year high
The NSW unemployment rate hit 4.7 per cent last month, the highest level since November 2021.
Eisen family spend chunk of Afterpay billions on swanky $12m Armadale shop
The couple moved to Melbourne around 2020 and paid $26 million for a Toorak mansion. They also splashed out $13 million on a “modest” Byron Bay pad.
Is Karl Stefanovic now Australia’s most famous small business owner?
In this week’s On Background, Stefanovic’s love fest at the CPAC Australia, ABC’s latest recruit gets a taste of what he is up against, and News24 goes gaga for MAGA.
Scheduling a 4.55pm meeting on Friday should be a workplace offence
If you want to work 10 or 12-hour days, go for it. But don’t force it on others and, for goodness’ (and your own) sake, leave Friday exempt.
Priscilla star Marney McQueen sells Wyong’s Royal for $22m, heads to Melb
Actress and pub owner Marney McQueen and her husband Frank Arangio are moving to Melbourne after selling their Central Coast pub for a whopping $22 million.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.